TANG CAPITAL MANAGEMENT LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
KROS
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:15:06 UTC
Date of event
31 Dec 2025
Previous filing
22 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 0% ownership in Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS) on 31 Dec 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS).
  • Disclosed ownership: 0%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 22 Oct 2025.
  • Current filing was accepted on 17 Feb 2026, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 0% 0 0 0 /s/ Kevin Tang Manager
KEVIN TANG 0% 0 0 0 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 0% 0 0 0 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 0% 0 0 0 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer

Sponsored